A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine.
- Proceedings of the National Academy of Sciences of the United States of America
|Paul-Ehrlich-Institut (PEI), Germany||0.68|
|The University of North Carolina at Chapel Hill (UNC), United States of America (USA)||0.18|
|DZIF Partner Site Giessen-Marburg-Langen, Germany||0.14|